247 related articles for article (PubMed ID: 23885694)
1. Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome.
Panidis D; Tziomalos K; Macut D; Kandaraki EA; Tsourdi EA; Papadakis E; Katsikis I
Gynecol Endocrinol; 2013 Oct; 29(10):926-30. PubMed ID: 23885694
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
[TBL] [Abstract][Full Text] [Related]
4. The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study.
Hosseinpanah F; Barzin M; Tehrani FR; Azizi F
Clin Endocrinol (Oxf); 2011 Nov; 75(5):692-7. PubMed ID: 21592169
[TBL] [Abstract][Full Text] [Related]
5. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
6. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
[TBL] [Abstract][Full Text] [Related]
7. Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome.
Ni RM; Mo Y; Chen X; Zhong J; Liu W; Yang D
Eur J Endocrinol; 2009 Sep; 161(3):411-8. PubMed ID: 19542239
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of metabolic syndrome in women with polycystic ovary syndrome.
Panidis D; Macut D; Tziomalos K; Papadakis E; Mikhailidis K; Kandaraki EA; Tsourdi EA; Tantanasis T; Mavromatidis G; Katsikis I
Clin Endocrinol (Oxf); 2013 Apr; 78(4):586-92. PubMed ID: 22888988
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome.
Hahn S; Tan S; Sack S; Kimmig R; Quadbeck B; Mann K; Janssen OE
Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):130-5. PubMed ID: 17318774
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.
Lankarani M; Valizadeh N; Heshmat R; Peimani M; Sohrabvand F
Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up.
Hudecova M; Holte J; Olovsson M; Larsson A; Berne C; Sundstrom-Poromaa I
Fertil Steril; 2011 Nov; 96(5):1271-4. PubMed ID: 21872228
[TBL] [Abstract][Full Text] [Related]
12. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.
Carmina E; Campagna AM; Lobo RA
Hum Reprod; 2013 Aug; 28(8):2245-52. PubMed ID: 23595974
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study.
Kyrkou G; Trakakis E; Attilakos A; Panagopoulos P; Chrelias C; Papadimitriou A; Vaggopoulos V; Alexiou E; Mastorakos G; Lykeridou A; Kassanos D; Papaevangelou V; Papantoniou N
Arch Gynecol Obstet; 2016 Apr; 293(4):915-23. PubMed ID: 26615602
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome.
Rossi B; Sukalich S; Droz J; Griffin A; Cook S; Blumkin A; Guzick DS; Hoeger KM
J Clin Endocrinol Metab; 2008 Dec; 93(12):4780-6. PubMed ID: 18812482
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women.
Boyle JA; Cunningham J; Norman RJ; Dunbar T; O'Dea K
Intern Med J; 2015 Dec; 45(12):1247-54. PubMed ID: 26387977
[TBL] [Abstract][Full Text] [Related]
16. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in polycystic ovary syndrome.
Carmina E
Minerva Ginecol; 2006 Apr; 58(2):109-14. PubMed ID: 16582867
[TBL] [Abstract][Full Text] [Related]
18. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
19. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
Goverde AJ; van Koert AJ; Eijkemans MJ; Knauff EA; Westerveld HE; Fauser BC; Broekmans FJ
Hum Reprod; 2009 Mar; 24(3):710-7. PubMed ID: 19095675
[TBL] [Abstract][Full Text] [Related]
20. Could "a body shape index" and "waist to height ratio" predict insulin resistance and metabolic syndrome in polycystic ovary syndrome?
Behboudi-Gandevani S; Ramezani Tehrani F; Cheraghi L; Azizi F
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():110-4. PubMed ID: 27579518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]